Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma

BACKGROUND: Treatment with programmed death receptor-1 (PD-1) antibodies is associated with high response rates in patients with advanced melanoma. Reliable markers for early response and outcome are still sparse. METHODS: We evaluated 66 consecutive patients with advanced/metastatic melanoma treate...

Descripción completa

Detalles Bibliográficos
Autores principales: Diem, S, Kasenda, B, Spain, L, Martin-Liberal, J, Marconcini, R, Gore, M, Larkin, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742588/
https://www.ncbi.nlm.nih.gov/pubmed/26794281
http://dx.doi.org/10.1038/bjc.2015.467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742588/
https://www.ncbi.nlm.nih.gov/pubmed/26794281
http://dx.doi.org/10.1038/bjc.2015.467

Ejemplares similares